L36-14806-89913
2 vaccinations
2 coded responses
8 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 751 / TX
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Pfizer-BioNTech
- 2021-04-01
-
2021-04-02
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Good · Site: PainFree text: Running nose (mild)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
- 2021-04-07
-
2021-04-08
Survey response — day 7, dose 1MedDRA: Upper-airway cough syndrome — Feeling: Good · Chills, HeadacheFree text: Throat drainageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Dose 2 — Pfizer-BioNTech
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-01
- 2021-05-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-29 | Pfizer-BioNTech |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Running nose (mild)
Release 7 — day 7, dose 1
Systemic reaction (other): Throat drainage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release